The cannabinoid CB1 receptor antagonist AM251 does not modify methamphetamine reinstatement of responding

Sherin Y. Boctor, Joe L. Martinez, Wouter Koek, Charles P. France

Research output: Contribution to journalArticlepeer-review

19 Scopus citations

Fingerprint

Dive into the research topics of 'The cannabinoid CB1 receptor antagonist AM251 does not modify methamphetamine reinstatement of responding'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience

Psychology

Nursing and Health Professions